[1]
N. Stepanova, L. Korol, V. Novakivskyy, and M. Kolesnyk, “The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients”, Ukr. J. Nephrol. Dial., no. 3(59), pp. 18-24, Sep. 2018.